Strata Critical Medical (SRTA) Non-Current Deffered Revenue (2019 - 2021)

Strata Critical Medical (SRTA) has 3 years of Non-Current Deffered Revenue data on file, last reported at $9.6 million in Q1 2021.

• Non-Current Deffered Revenue for Q1 2021 came in at $9.6 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2021 was $9.6 million (changed 0.0% YoY), and the FY2020 annual result was $9.6 million, changed N/A from the prior year.
• Non-Current Deffered Revenue steadied at $9.6 million in Q1 2021 per SRTA's latest filing, from $9.6 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $9.6 million in Q3 2019 and troughed at $9.6 million in Q3 2019.
• A 3-year average of $9.6 million and a median of $9.6 million in 2019 frame the typical range for Non-Current Deffered Revenue.
• On a YoY basis, Non-Current Deffered Revenue climbed as much as 0.0% in 2020 and fell as far as 0.0% in 2020.
• A 3-year view of Non-Current Deffered Revenue shows it stood at $9.6 million in 2019, then changed by 0.0% to $9.6 million in 2020, then changed by 0.0% to $9.6 million in 2021.
• Business Quant data shows SRTA's Non-Current Deffered Revenue at $9.6 million in Q1 2021, $9.6 million in Q4 2020, and $9.6 million in Q3 2020.